Table 1.
Statistical comparisons of demographic characteristics and clinical parameters between NC and T2DM groups.
| Parameters | NC group n = 50 | T2DM group n = 50 | ||
|---|---|---|---|---|
| χ 2 | P- value | |||
| Male gender, n (%) | 29 (58%) | 26 (52%) | 0.364 | 0.546 |
| Smoking, n (%) | 12 (24%) | 14 (28%) | 0.208 | 0.648 |
| t | P- value | |||
| Age (years) | 46.88 ± 10.60 | 50.20 ± 9.73 | −1.632 | 0.106 |
| BMI (kg/m2) | 24.32 ± 3.67 | 26.09 ± 3.80 | −2.370 | 0.020 |
| BSA (m2) | 1.72 ± 0.16 | 1.83 ± 0.24 | −2.449 | 0.016 |
| SBP (mm Hg) | 118.84 ± 3.94 | 120.68 ± 6.00 | −1.813 | 0.073 |
| DBP (mm Hg) | 77.70 ± 6.31 | 79.24 ± 7.40 | −1.120 | 0.265 |
| pulse pressure (mm Hg) | 41.14 ± 7.13 | 41.44 ± 8.85 | −0.187 | 0.852 |
| Heart rate (bpm) | 67.82 ± 8.37 | 71.02 ± 9.41 | −1.797 | 0.075 |
| TC (mmol/L) | 4.33 ± 0.61 | 4.50 ± 1.01 | −0.957 | 0.341 |
| TG (mmol/L) | 1.65 ± 0.64 | 2.17 ± 1.04 | −2.296 | 0.004 |
| LDL-C (mmol/L) | 2.48 ± 0.70 | 2.79 ± 0.66 | −2.196 | 0.030 |
| HbA1c (%) | 5.24 ± 0.36 | 8.06 ± 1.37 | −10.350 | <0.001 |
| Z | P- value | |||
| HDL-C (mmol/L) | 1.01 (0.30) | 1.03 (0.23) | −0.259 | 0.796 |
| FPG (mmol/L) | – | 7.88 ± 1.49 | – | – |
| 2h-PPG (mmol/L) | – | 11.60 ± 2.32 | – | – |
| Diabetes duration (years) | – | 2.50 (9.37) | – | – |
| Oral antihyperglycemic agent, n (%) | – | 23 (46%) | – | – |
| Insulin, n (%) | – | 3 (6%) | – | – |
| Oral antihyperglycemic agent + insulin, n (%) | – | 14 (28%) | – | – |
| Complications, n (%) | – | 11 (22%) | – | – |
| Cardiovascular medications, n (%) | – | 13 (26%) | – | – |
T2DM, type 2 diabetes mellitus; NC, normal control; BMI, body mass index;BSA, body surface area; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, hemoglobin A1c; FPG, fasting plasma glucose; 2h-PPG, 2-h postprandial plasma glucose; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.